secwatch / observer
8-K/A filed May 5, 2023, 7:59 PM ET ticker LH CIK 0000920148
leadership confidence high sentiment neutral materiality 0.50

Labcorp appoints Mark Schroeder EVP, President Diagnostics & COO; awards equity valued at $500k

LABCORP HOLDINGS INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mark S. Schroeder

Executive Vice President, President Diagnostics & Chief Operations Officer
LH · LABCORP HOLDINGS INC.
Effective
2023-05-01
Filed
May 5, 2023, 7:59 PM ET
on May 4, 2023, Labcorp announced that Mark S. Schroeder, the current Executive Vice President, and President, Diagnostics Laboratory Operations and Global Supply Chain of Labcorp, a named executive officer, has been appointed to the position of Executive Vice President, President Diagnostics & Chief Operations Officer, effective May 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Mark S. Schroeder was appointed as Executive Vice President, President Diagnostics & Chief Operations Officer at LABCORP HOLDINGS INC..

Action
appointed
Role
Executive Vice President, President Diagnostics & Chief Operations Officer
Exact text from the filing
on May 4, 2023, Labcorp announced that Mark S. Schroeder, the current Executive Vice President, and President, Diagnostics Laboratory Operations and Global Supply Chain of Labcorp, a named executive officer, has been appointed to the position of Executive Vice President, President Diagnostics & Chief Operations Officer, effective May 1, 2023.
View on SEC.gov

LABCORP HOLDINGS INC. filing history →

Source: SEC EDGAR
accession 0000920148-23-000035
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.